UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Steady‐State Head‐to‐Head Pharmacokinetic Comparison of All FK‐506 (Tacrolimus) Formulations (ASTCOFF): An Open‐Label, Prospective, Randomized, Two‐Arm, Three‐Period Crossover Study

American journal of transplantation, 2017-02, Vol.17 (2), p.432-442

2017

Volltextzugriff (PDF)

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

Transplantation, 2008-12, Vol.86 (12), p.1754-1761

2008

Volltextzugriff (PDF)

Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial

PLoS medicine, 2017-11, Vol.14 (11), p.e1002428-e1002428

2017

Volltextzugriff (PDF)

Prospective Iterative Trial of Proteasome Inhibitor‐Based Desensitization

American journal of transplantation, 2015-01, Vol.15 (1), p.101-118

2015

Volltextzugriff (PDF)

A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients

American journal of transplantation, 2012-10, Vol.12 (10), p.2825-2831

2012

Volltextzugriff (PDF)

Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection

Transplantation, 2010-02, Vol.89 (3), p.277-284

2010

Volltextzugriff (PDF)

Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients

Transplantation, 2013-07, Vol.96 (2), p.191-197

2013

Volltextzugriff (PDF)

Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward

American journal of transplantation, 2016-04, Vol.16 (4), p.1094-1101

2016

Volltextzugriff (PDF)

Plasma cell biology: Foundations for targeted therapeutic development in transplantation

Immunological reviews, 2021-09, Vol.303 (1), p.168-186

2021

Volltextzugriff (PDF)

Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality

The Journal of clinical investigation, 2023-07, Vol.133 (14)

2023

Volltextzugriff (PDF)

Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients

American journal of transplantation, 2018-02, Vol.18 (2), p.410-416

2018

Volltextzugriff (PDF)

Proteasome inhibitor-based therapy for antibody-mediated rejection

Kidney international, 2012-06, Vol.81 (11), p.1067-1074

2012

Volltextzugriff (PDF)

Evolution of the Role of the Transplant Pharmacist on the Multidisciplinary Transplant Team

American journal of transplantation, 2011-08, Vol.11 (8), p.1576-1583

2011

Volltextzugriff (PDF)

Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

American journal of transplantation, 2009-05, Vol.9 (5), p.1063-1071

2009

Volltextzugriff (PDF)

De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population

Transplantation, 2009-05, Vol.87 (9), p.1347-1359

2009

Volltextzugriff (PDF)

Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition

Transplantation, 2011-06, Vol.91 (11), p.1218-1226

2011

Volltextzugriff (PDF)

Randomized Controlled Pilot Study of B Cell–Targeted Induction Therapy in HLA Sensitized Kidney Transplant Recipients

American journal of transplantation, 2013-12, Vol.13 (12), p.3142-3154

2013

Volltextzugriff (PDF)

Conversion from twice daily tacrolimus capsules to once daily extended‐release tacrolimus (LCP‐Tacro): Phase 2 trial of stable liver transplant recipients

Liver transplantation, 2014-05, Vol.20 (5), p.564-575

2014

Volltextzugriff (PDF)

Addressing Morbid Obesity as a Barrier to Renal Transplantation With Laparoscopic Sleeve Gastrectomy

American journal of transplantation, 2015-05, Vol.15 (5), p.1360-1368

2015

Volltextzugriff (PDF)

A Theoretical Physiologically‐Based Pharmacokinetic Approach to Ascertain Covariates Explaining the Large Interpatient Variability in Tacrolimus Disposition

CPT: pharmacometrics and systems pharmacology, 2019-05, Vol.8 (5), p.273-284

2019

Volltextzugriff (PDF)

Reply to “Fluctuation Does Not Mean Variability: A Pharmacokinetic Point of View”

American journal of transplantation, 2017-06, Vol.17 (6), p.1693-1693

2017

Volltextzugriff (PDF)

Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case Report

Transplantation proceedings, 2017-01, Vol.49 (1), p.188-192

2017

Volltextzugriff (PDF)

Proteasome inhibitor therapy for antibody-mediated rejection

Pediatric transplantation, 2011-09, Vol.15 (6), p.548-556

2011

Volltextzugriff (PDF)

Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients

Transplantation, 2012-08, Vol.94 (4), p.352-361

2012

Volltextzugriff (PDF)

Evidence of a clinically significant drug‐drug interaction between cannabidiol and tacrolimus

American journal of transplantation, 2019-10, Vol.19 (10), p.2944-2948

2019

Volltextzugriff (PDF)

1 – 25 von 537

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(492)
Mit Volltextzugriff
(322)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(534)
Deutsch
(3)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(298)
Life Sciences & Biomedicine
(238)
Humans
(203)
Transplantation
(151)
Surgery
(150)
Male
(129)
Biological And Medical Sciences
(126)
Medical Sciences
(119)
Female
(116)
Adult
(101)
Immunology
(90)
Middle Aged
(89)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(77)
Immunosuppressive Agents - Therapeutic Use
(67)
Kidney Transplantation
(67)
Physical Sciences
(51)
Treatment Outcome
(50)
Kidney Transplantation - Immunology
(48)
Prospective Studies
(46)
Fundamental And Applied Biological Sciences. Psychology
(45)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A Steady‐State Head‐to‐Head Pharmacokinetic Comparison of All FK‐506 (Tacrolimus) Formulations (ASTCOFF): An Open‐Label, Prospective, Randomized, Two‐Arm, Three‐Period Crossover Study

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial

Prospective Iterative Trial of Proteasome Inhibitor‐Based Desensitization

A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients

Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection

Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients

Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward

Plasma cell biology: Foundations for targeted therapeutic development in transplantation

Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality

Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients

Proteasome inhibitor-based therapy for antibody-mediated rejection

Evolution of the Role of the Transplant Pharmacist on the Multidisciplinary Transplant Team

Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population

Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition

Randomized Controlled Pilot Study of B Cell–Targeted Induction Therapy in HLA Sensitized Kidney Transplant Recipients

Conversion from twice daily tacrolimus capsules to once daily extended‐release tacrolimus (LCP‐Tacro): Phase 2 trial of stable liver transplant recipients

Addressing Morbid Obesity as a Barrier to Renal Transplantation With Laparoscopic Sleeve Gastrectomy

A Theoretical Physiologically‐Based Pharmacokinetic Approach to Ascertain Covariates Explaining the Large Interpatient Variability in Tacrolimus Disposition

Reply to “Fluctuation Does Not Mean Variability: A Pharmacokinetic Point of View”

Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case Report

Proteasome inhibitor therapy for antibody-mediated rejection

Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients

Evidence of a clinically significant drug‐drug interaction between cannabidiol and tacrolimus

Suchergebnisse filtern